Kynam Capital Management, LP 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
KC Kynam Capital Management, LP | Institutional Filer | ▲ 2.49% | $1.60B | 36 |
Current Portfolio Holdings
Showing all 36 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | SNDX | Syndax Pharmaceuticals, Inc. | Healthcare | 8.1M | $188.1M | 11.75% |
| 2 | CLDX | Celldex Therapeutics, Inc. | Healthcare | 5.8M | $185.3M | 11.57% |
| 3 | PCVX | Vaxcyte, Inc. | Healthcare | 2.9M | $169.8M | 10.61% |
| 4 | COGT | Cogent Biosciences, Inc. | Healthcare | 4.0M | $155.4M | 9.71% |
| 5 | VERA | Vera Therapeutics, Inc. | Healthcare | 3.4M | $136.7M | 8.54% |
| 6 | BEAM | Beam Therapeutics Inc. | Healthcare | 3.7M | $87.7M | 5.48% |
| 7 | TVTX | Travere Therapeutics, Inc. | Healthcare | 2.4M | $72.0M | 4.50% |
| 8 | CTMX | CytomX Therapeutics, Inc. | Healthcare | 15.0M | $70.6M | 4.41% |
| 9 | BCRX | BioCryst Pharmaceuticals, Inc. | Healthcare | 5.7M | $54.1M | 3.38% |
| 10 | VRDN | Viridian Therapeutics, Inc. | Healthcare | 2.3M | $45.8M | 2.86% |
| 11 | CGEM | Cullinan Therapeutics, Inc. | Healthcare | 3.1M | $44.3M | 2.76% |
| 12 | URGN | UroGen Pharma Ltd. | Healthcare | 2.2M | $40.4M | 2.52% |
| 13 | KALV | KalVista Pharmaceuticals, Inc. | Healthcare | 1.8M | $36.7M | 2.29% |
| 14 | APLS | Apellis Pharmaceuticals, Inc. | Healthcare | 825K | $33.2M | 2.07% |
| 15 | LEGN | Legend Biotech Corporation | Healthcare | 1.6M | $28.5M | 1.78% |
Showing 1 to 15 of 36 holdings